Rare Biomarkers Specimen Collection & Stabilization Market

The Rare Biomarkers Specimen Collection & Stabilization Market is redefining sample management for clinical and research settings, prioritizing specimen integrity and operational efficiency amid changing global demands. Senior leaders face critical decisions regarding technology adoption, compliance, and workflow optimization in this evolving field.

Market Snapshot: Rare Biomarkers Specimen Collection & Stabilization Market

The Rare Biomarkers Specimen Collection & Stabilization Market is projected to grow from USD 34.71 billion in 2025 to USD 37.41 billion in 2026, and is anticipated to reach USD 59.52 billion by 2032 at a compound annual growth rate (CAGR) of 8.00%. Continuous investment in clinical diagnostics, an industry-wide shift toward minimally invasive procedures, and increasing focus from regulatory authorities are driving adoption of efficient, high-quality specimen collection and stabilization technologies worldwide. The robust demand for flexible, standardized solutions is expected to support both clinical and translational research workflows, ensuring reliability across decentralized and centralized laboratories.

Scope & Segmentation

Product Categories: Includes blood collection tubes, specialized isolation kits, advanced reagents, and integrated collection systems, each engineered to address priorities like analyte preservation and workflow compatibility.
Specimen Types: Encompasses circulating cell-free DNA, cell-free RNA, circulating tumor cells, exosomes, and extracellular vesicles, with each offering unique stabilization and separation needs according to clinical and research use cases.
Stabilization Modalities: Features chemical stabilization, lyophilization, freezing, and refrigeration, providing tailored options to accommodate logistical, analytical, and storage requirements in both routine and specialized environments.
Collection Approaches: Covers both automated and manual procedural techniques, supporting varying laboratory throughputs, reproducibility goals, and adaptability in clinical as well as decentralized or resource-limited environments.
Applications: Supports genetic analysis, infectious disease monitoring, neurology investigations, oncology diagnostics, and a broad spectrum of translational research needs, ensuring market relevance across healthcare and life sciences sectors.
End Users: Serves hospital laboratories, diagnostic centers, contract research organizations, and research institutes, each segment prioritizing sample quality, operational compliance, and custom workflow design.
Regions: Provides comprehensive analysis of trends in the Americas, Europe, Middle East & Africa, and Asia-Pacific, accounting for adoption patterns, regional regulations, operational disparities, and unique infrastructural challenges.
Technologies: Incorporates validated collection chemistries, automation platforms, ambient-stable formats, and closed-system workflows, enabling robust sample management from collection to analysis.

Key Takeaways for Senior Decision-Makers

Preserving biomarker stability underpins the credibility of clinical and research findings and calls for validated protocols that seamlessly integrate into operational workflows.
Heightened regulatory standards are shaping procurement strategies, leading organizations to prioritize partners with robust pre-analytical quality controls and clear compliance pathways.
Adoption of room temperature-stable chemistries and automated systems addresses both logistics simplification and expansion of testing access, particularly for decentralized or under-resourced settings.
Strategic collaborations among technology providers, clinical sites, and research organizations are accelerating the standardization of advanced stabilization methods, resulting in enhanced reliability and easier scalability.
Regional differences in reimbursement, privacy policies, and transport infrastructure necessitate adaptable strategies for deployment and market entry, requiring providers to align solutions with diverse regulatory landscapes.
Competitive differentiation is increasingly linked to the depth of validation evidence, flexibility of product portfolios, and resilience of supply chain networks.

Tariff Impact on Procurement and Supply Chains

The introduction of new tariffs in the United States in 2025 has reshaped procurement frameworks in the specimen collection and stabilization sector. Procurement leads are broadening their supplier base, exploring nearshore sourcing, and emphasizing total landed costs to better manage financial unpredictability. Clinical and research laboratories are refining inventory strategies and assessing domestic alternatives to minimize supply disruptions. Parallelly, innovation teams are evaluating new materials and streamlined packaging to strengthen operational resilience when adapting to ongoing changes in trade policies.

Methodology & Data Sources

This report is informed by primary interviews with laboratory directors, clinical trial sponsors, procurement leads, and technical experts, supported by comprehensive quantitative surveys and supply chain analysis. Independent validation studies and peer-reviewed publications contribute to ensuring both technical accuracy and practical insights for executive decision-making.

Why This Report Matters

Enables senior leaders to implement pre-analytical workflows that align with the latest regulatory standards and equip organizations for scalable growth.
Offers clear frameworks to bolster supply chain flexibility and operational continuity amid evolving global trade environments.
Equips decision-makers with the market intelligence needed to optimize product choices, regional strategies, and technology integration, enhancing sample quality and cost management.

Conclusion

Investing strategically in validated stabilization processes, adaptable logistics, and resilient supply chains equips organizations for success in a market characterized by operational complexity and evolving regulatory demands. Prioritizing these elements supports reliable, high-value outcomes across both clinical and research domains.

Additional Product Information:

Purchase of this report includes 1 year online access with quarterly updates.
This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

1. Preface

1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders

2. Research Methodology

2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations

3. Executive Summary

3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap

4. Market Overview

4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy

5. Market Insights

5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025

8. Rare Biomarkers Specimen Collection & Stabilization Market, by Product

8.1. Blood Collection Tubes
8.2. Isolation Kits & Reagents
8.3. Systems

9. Rare Biomarkers Specimen Collection & Stabilization Market, by Specimen Type

9.1. ccfDNA
9.2. ccfRNA
9.3. CTCs
9.4. Exosomes/Extracellular Vesicles

10. Rare Biomarkers Specimen Collection & Stabilization Market, by Stabilization Technique

10.1. Chemical
10.2. Lyophilization
10.3. Temperature Control
10.3.1. Freezing
10.3.2. Refrigeration

11. Rare Biomarkers Specimen Collection & Stabilization Market, by Collection Method

11.1. Automated
11.2. Manual

12. Rare Biomarkers Specimen Collection & Stabilization Market, by Application

12.1. Genetic Testing
12.2. Infectious Disease
12.3. Neurology
12.4. Oncology

13. Rare Biomarkers Specimen Collection & Stabilization Market, by End User

13.1. Cros
13.2. Diagnostic Centers
13.3. Hospital Laboratories
13.4. Research Institutes

14. Rare Biomarkers Specimen Collection & Stabilization Market, by Region

14.1. Americas
14.1.1. North America
14.1.2. Latin America
14.2. Europe, Middle East & Africa
14.2.1. Europe
14.2.2. Middle East
14.2.3. Africa
14.3. Asia-Pacific

15. Rare Biomarkers Specimen Collection & Stabilization Market, by Group

15.1. ASEAN
15.2. GCC
15.3. European Union
15.4. BRICS
15.5. G7
15.6. NATO

16. Rare Biomarkers Specimen Collection & Stabilization Market, by Country

16.1. United States
16.2. Canada
16.3. Mexico
16.4. Brazil
16.5. United Kingdom
16.6. Germany
16.7. France
16.8. Russia
16.9. Italy
16.10. Spain
16.11. China
16.12. India
16.13. Japan
16.14. Australia
16.15. South Korea

17. United States Rare Biomarkers Specimen Collection & Stabilization Market
18. China Rare Biomarkers Specimen Collection & Stabilization Market

19. Competitive Landscape

19.1. Market Concentration Analysis, 2025
19.1.1. Concentration Ratio (CR)
19.1.2. Herfindahl Hirschman Index (HHI)
19.2. Recent Developments & Impact Analysis, 2025
19.3. Product Portfolio Analysis, 2025
19.4. Benchmarking Analysis, 2025
19.5. Adaptive Biotechnologies Corporation
19.6. Angle plc
19.7. Becton, Dickinson and Company
19.8. Bio-Rad Laboratories, Inc.
19.9. Biomatrica, Inc.
19.10. Burning Rock Biotech Limited
19.11. Delfi Diagnostics, Inc.
19.12. DNA Genotek Inc.
19.13. Exact Sciences Corporation
19.14. Freenome Holdings, Inc.
19.15. Guardant Health, Inc.
19.16. Invivoscribe, Inc.
19.17. Merck KGaA
19.18. MiRXES Pte Ltd.
19.19. Natera, Inc.
19.20. Norgen Biotek Corp.
19.21. Personalis, Inc.
19.22. PreAnalytiX GmbH
19.23. QIAGEN N.V.
19.24. Roche Diagnostics Corporation
19.25. Roche Holding AG
19.26. Streck, Inc.
19.27. Sysmex Corporation
19.28. Thermo Fisher Scientific Inc.

List of Figures

FIGURE 1. GLOBAL RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY PRODUCT, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY SPECIMEN TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY STABILIZATION TECHNIQUE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COLLECTION METHOD, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. GLOBAL RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 13. UNITED STATES RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 14. CHINA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, 2018-2032 (USD MILLION)

List of Tables

TABLE 1. GLOBAL RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY BLOOD COLLECTION TUBES, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY BLOOD COLLECTION TUBES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY BLOOD COLLECTION TUBES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY ISOLATION KITS & REAGENTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY ISOLATION KITS & REAGENTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY ISOLATION KITS & REAGENTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY SPECIMEN TYPE, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY CCFDNA, BY REGION, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY CCFDNA, BY GROUP, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY CCFDNA, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY CCFRNA, BY REGION, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY CCFRNA, BY GROUP, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY CCFRNA, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY CTCS, BY REGION, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY CTCS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY CTCS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY EXOSOMES/EXTRACELLULAR VESICLES, BY REGION, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY EXOSOMES/EXTRACELLULAR VESICLES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY EXOSOMES/EXTRACELLULAR VESICLES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY STABILIZATION TECHNIQUE, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY CHEMICAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY CHEMICAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY CHEMICAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY LYOPHILIZATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY LYOPHILIZATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY LYOPHILIZATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY TEMPERATURE CONTROL, BY REGION, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY TEMPERATURE CONTROL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY TEMPERATURE CONTROL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY TEMPERATURE CONTROL, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY FREEZING, BY REGION, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY FREEZING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY FREEZING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY REFRIGERATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY REFRIGERATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY REFRIGERATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COLLECTION METHOD, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY AUTOMATED, BY REGION, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY AUTOMATED, BY GROUP, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY AUTOMATED, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY MANUAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY MANUAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY MANUAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY GENETIC TESTING, BY REGION, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY GENETIC TESTING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY GENETIC TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY INFECTIOUS DISEASE, BY REGION, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY INFECTIOUS DISEASE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY INFECTIOUS DISEASE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY NEUROLOGY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY NEUROLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY ONCOLOGY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY ONCOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY CROS, BY REGION, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY CROS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY CROS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY DIAGNOSTIC CENTERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY DIAGNOSTIC CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY HOSPITAL LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY HOSPITAL LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY HOSPITAL LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 76. AMERICAS RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 77. AMERICAS RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 78. AMERICAS RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY SPECIMEN TYPE, 2018-2032 (USD MILLION)
TABLE 79. AMERICAS RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY STABILIZATION TECHNIQUE, 2018-2032 (USD MILLION)
TABLE 80. AMERICAS RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY TEMPERATURE CONTROL, 2018-2032 (USD MILLION)
TABLE 81. AMERICAS RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COLLECTION METHOD, 2018-2032 (USD MILLION)
TABLE 82. AMERICAS RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 83. AMERICAS RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 84. NORTH AMERICA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 85. NORTH AMERICA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 86. NORTH AMERICA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY SPECIMEN TYPE, 2018-2032 (USD MILLION)
TABLE 87. NORTH AMERICA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY STABILIZATION TECHNIQUE, 2018-2032 (USD MILLION)
TABLE 88. NORTH AMERICA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY TEMPERATURE CONTROL, 2018-2032 (USD MILLION)
TABLE 89. NORTH AMERICA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COLLECTION METHOD, 2018-2032 (USD MILLION)
TABLE 90. NORTH AMERICA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 91. NORTH AMERICA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 92. LATIN AMERICA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 93. LATIN AMERICA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 94. LATIN AMERICA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY SPECIMEN TYPE, 2018-2032 (USD MILLION)
TABLE 95. LATIN AMERICA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY STABILIZATION TECHNIQUE, 2018-2032 (USD MILLION)
TABLE 96. LATIN AMERICA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY TEMPERATURE CONTROL, 2018-2032 (USD MILLION)
TABLE 97. LATIN AMERICA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COLLECTION METHOD, 2018-2032 (USD MILLION)
TABLE 98. LATIN AMERICA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 99. LATIN AMERICA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 100. EUROPE, MIDDLE EAST & AFRICA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 101. EUROPE, MIDDLE EAST & AFRICA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 102. EUROPE, MIDDLE EAST & AFRICA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY SPECIMEN TYPE, 2018-2032 (USD MILLION)
TABLE 103. EUROPE, MIDDLE EAST & AFRICA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY STABILIZATION TECHNIQUE, 2018-2032 (USD MILLION)
TABLE 104. EUROPE, MIDDLE EAST & AFRICA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY TEMPERATURE CONTROL, 2018-2032 (USD MILLION)
TABLE 105. EUROPE, MIDDLE EAST & AFRICA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COLLECTION METHOD, 2018-2032 (USD MILLION)
TABLE 106. EUROPE, MIDDLE EAST & AFRICA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 107. EUROPE, MIDDLE EAST & AFRICA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 108. EUROPE RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 109. EUROPE RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 110. EUROPE RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY SPECIMEN TYPE, 2018-2032 (USD MILLION)
TABLE 111. EUROPE RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY STABILIZATION TECHNIQUE, 2018-2032 (USD MILLION)
TABLE 112. EUROPE RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY TEMPERATURE CONTROL, 2018-2032 (USD MILLION)
TABLE 113. EUROPE RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COLLECTION METHOD, 2018-2032 (USD MILLION)
TABLE 114. EUROPE RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 115. EUROPE RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 116. MIDDLE EAST RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 117. MIDDLE EAST RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 118. MIDDLE EAST RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY SPECIMEN TYPE, 2018-2032 (USD MILLION)
TABLE 119. MIDDLE EAST RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY STABILIZATION TECHNIQUE, 2018-2032 (USD MILLION)
TABLE 120. MIDDLE EAST RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY TEMPERATURE CONTROL, 2018-2032 (USD MILLION)
TABLE 121. MIDDLE EAST RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COLLECTION METHOD, 2018-2032 (USD MILLION)
TABLE 122. MIDDLE EAST RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 123. MIDDLE EAST RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 124. AFRICA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 125. AFRICA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 126. AFRICA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY SPECIMEN TYPE, 2018-2032 (USD MILLION)
TABLE 127. AFRICA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY STABILIZATION TECHNIQUE, 2018-2032 (USD MILLION)
TABLE 128. AFRICA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY TEMPERATURE CONTROL, 2018-2032 (USD MILLION)
TABLE 129. AFRICA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COLLECTION METHOD, 2018-2032 (USD MILLION)
TABLE 130. AFRICA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 131. AFRICA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 132. ASIA-PACIFIC RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 133. ASIA-PACIFIC RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 134. ASIA-PACIFIC RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY SPECIMEN TYPE, 2018-2032 (USD MILLION)
TABLE 135. ASIA-PACIFIC RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY STABILIZATION TECHNIQUE, 2018-2032 (USD MILLION)
TABLE 136. ASIA-PACIFIC RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY TEMPERATURE CONTROL, 2018-2032 (USD MILLION)
TABLE 137. ASIA-PACIFIC RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COLLECTION METHOD, 2018-2032 (USD MILLION)
TABLE 138. ASIA-PACIFIC RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 139. ASIA-PACIFIC RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 140. GLOBAL RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 141. ASEAN RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 142. ASEAN RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 143. ASEAN RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY SPECIMEN TYPE, 2018-2032 (USD MILLION)
TABLE 144. ASEAN RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY STABILIZATION TECHNIQUE, 2018-2032 (USD MILLION)
TABLE 145. ASEAN RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY TEMPERATURE CONTROL, 2018-2032 (USD MILLION)
TABLE 146. ASEAN RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COLLECTION METHOD, 2018-2032 (USD MILLION)
TABLE 147. ASEAN RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 148. ASEAN RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 149. GCC RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 150. GCC RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 151. GCC RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY SPECIMEN TYPE, 2018-2032 (USD MILLION)
TABLE 152. GCC RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY STABILIZATION TECHNIQUE, 2018-2032 (USD MILLION)
TABLE 153. GCC RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY TEMPERATURE CONTROL, 2018-2032 (USD MILLION)
TABLE 154. GCC RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COLLECTION METHOD, 2018-2032 (USD MILLION)
TABLE 155. GCC RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 156. GCC RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 157. EUROPEAN UNION RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 158. EUROPEAN UNION RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 159. EUROPEAN UNION RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY SPECIMEN TYPE, 2018-2032 (USD MILLION)
TABLE 160. EUROPEAN UNION RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY STABILIZATION TECHNIQUE, 2018-2032 (USD MILLION)
TABLE 161. EUROPEAN UNION RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY TEMPERATURE CONTROL, 2018-2032 (USD MILLION)
TABLE 162. EUROPEAN UNION RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COLLECTION METHOD, 2018-2032 (USD MILLION)
TABLE 163. EUROPEAN UNION RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 164. EUROPEAN UNION RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 165. BRICS RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 166. BRICS RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 167. BRICS RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY SPECIMEN TYPE, 2018-2032 (USD MILLION)
TABLE 168. BRICS RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY STABILIZATION TECHNIQUE, 2018-2032 (USD MILLION)
TABLE 169. BRICS RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY TEMPERATURE CONTROL, 2018-2032 (USD MILLION)
TABLE 170. BRICS RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COLLECTION METHOD, 2018-2032 (USD MILLION)
TABLE 171. BRICS RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 172. BRICS RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 173. G7 RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 174. G7 RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 175. G7 RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY SPECIMEN TYPE, 2018-2032 (USD MILLION)
TABLE 176. G7 RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY STABILIZATION TECHNIQUE, 2018-2032 (USD MILLION)
TABLE 177. G7 RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY TEMPERATURE CONTROL, 2018-2032 (USD MILLION)
TABLE 178. G7 RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COLLECTION METHOD, 2018-2032 (USD MILLION)
TABLE 179. G7 RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 180. G7 RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 181. NATO RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 182. NATO RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 183. NATO RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY SPECIMEN TYPE, 2018-2032 (USD MILLION)
TABLE 184. NATO RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY STABILIZATION TECHNIQUE, 2018-2032 (USD MILLION)
TABLE 185. NATO RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY TEMPERATURE CONTROL, 2018-2032 (USD MILLION)
TABLE 186. NATO RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COLLECTION METHOD, 2018-2032 (USD MILLION)
TABLE 187. NATO RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 188. NATO RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 189. GLOBAL RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 190. UNITED STATES RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 191. UNITED STATES RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 192. UNITED STATES RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY SPECIMEN TYPE, 2018-2032 (USD MILLION)
TABLE 193. UNITED STATES RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY STABILIZATION TECHNIQUE, 2018-2032 (USD MILLION)
TABLE 194. UNITED STATES RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY TEMPERATURE CONTROL, 2018-2032 (USD MILLION)
TABLE 195. UNITED STATES RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COLLECTION METHOD, 2018-2032 (USD MILLION)
TABLE 196. UNITED STATES RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 197. UNITED STATES RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 198. CHINA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 199. CHINA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 200. CHINA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY SPECIMEN TYPE, 2018-2032 (USD MILLION)
TABLE 201. CHINA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY STABILIZATION TECHNIQUE, 2018-2032 (USD MILLION)
TABLE 202. CHINA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY TEMPERATURE CONTROL, 2018-2032 (USD MILLION)
TABLE 203. CHINA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COLLECTION METHOD, 2018-2032 (USD MILLION)
TABLE 204. CHINA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 205. CHINA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)

Companies Mentioned

The key companies profiled in this Rare Biomarkers Specimen Collection & Stabilization market report include:

Adaptive Biotechnologies Corporation
Angle plc
Becton, Dickinson and Company
Bio-Rad Laboratories, Inc.
Biomatrica, Inc.
Burning Rock Biotech Limited
Delfi Diagnostics, Inc.
DNA Genotek Inc.
Exact Sciences Corporation
Freenome Holdings, Inc.
Guardant Health, Inc.
Invivoscribe, Inc.
Merck KGaA
MiRXES Pte Ltd.
Natera, Inc.
Norgen Biotek Corp.
Personalis, Inc.
PreAnalytiX GmbH
QIAGEN N.V.
Roche Diagnostics Corporation
Roche Holding AG
Streck, Inc.
Sysmex Corporation
Thermo Fisher Scientific Inc.

Table Information

Report Attribute	Details
No. of Pages	197
Published	January 2026
Forecast Period	2026 - 2032
Estimated Market Value ( USD ) in 2026	$ 37.41 Billion
Forecasted Market Value ( USD ) by 2032	$ 59.52 Billion
Compound Annual Growth Rate	8.0%
Regions Covered	Global
No. of Companies Mentioned	24

License	Properties	Price
SINGLE USER LICENSE PDF, Excel and Online Access	This is a single user license, allowing one user access to the product.	€3504EUR$3,939USD£3,037GBP
1 - 5 USER LICENSE PDF, Excel and Online Access	This is a 1-5 user license, allowing up to five users have access to the product.	€3779EUR$4,249USD£3,276GBP
SITE LICENSE PDF, Excel and Online Access	This is a site license, allowing all users within a given geographical location of your organization access to the product.	€5123EUR$5,759USD£4,440GBP
ENTERPRISE LICENSE PDF, Excel and Online Access	This is an enterprise license, allowing all employees within your organization access to the product.	€6199EUR$6,969USD£5,372GBP

Rare Biomarkers Specimen Collection & Stabilization Market - Global Forecast 2026-2032

Market Snapshot: Rare Biomarkers Specimen Collection & Stabilization Market

Scope & Segmentation

Key Takeaways for Senior Decision-Makers

Tariff Impact on Procurement and Supply Chains

Methodology & Data Sources

Why This Report Matters

Conclusion

Table of Contents

Companies Mentioned

Table Information

Market Snapshot: Rare Biomarkers Specimen Collection & Stabilization Market

Scope & Segmentation

Key Takeaways for Senior Decision-Makers

Tariff Impact on Procurement and Supply Chains

Methodology & Data Sources

Why This Report Matters

Conclusion

Table of Contents

Companies Mentioned

Table Information

Related Topics

Related Reports

Rare Biomarkers Specimen Collection and Stabilization - Global Strategic Business Report

Rare Biomarkers Specimen Collection and Stabilization Market Report 2025

Circulating Tumor Cells Market Report 2025

Circulating Tumor Cells Market Size, Share & Trends Analysis Report By Application (Clinical, Research), By Specimen (Bone Marrow, Blood), By Product, By Technology, By End Use, By Region, And Segment Forecasts, 2025 - 2030

Circulating Tumor Cells Global Market Insights 2026, Analysis and Forecast to 2031